← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Malaria Vaccine Development Center
Cali
$3,199,817
Total funding
3
Grants
Funding over time
peak $424.7K · FY2008–19$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,199,817 · 3
By mechanism
R01$2,875,817 · 2
R21$324,000 · 1
Investigators at Malaria Vaccine Development Center
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Plasmodium vivax 48/45 gametocyte protein: functional characterization and vaccine potential assessment in preclinical studies$424,745
R01 · FY2017 · AI
Plasmodium vivax 48/45 gametocyte protein: functional characterization and vaccine potential assessment in preclinical studies$420,950
R01 · FY2018 · AI
Plasmodium vivax 48/45 gametocyte protein: functional characterization and vaccine potential assessment in preclinical studies$416,829
R01 · FY2016 · AI
Plasmodium vivax 48/45 gametocyte protein: functional characterization and vaccine potential assessment in preclinical studies$375,545
R01 · FY2019 · AI
Development of a P. vivax immunization and sporozoite challenge model for human$370,784
R01 · FY2008 · HL
Development of a P. vivax immunization and sporozoite challenge model for human$343,157
R01 · FY2009 · HL
Development of a P. vivax immunization and sporozoite challenge model for human$263,020
R01 · FY2010 · HL
Development of a P. vivax immunization and sporozoite challenge model for human$260,787
R01 · FY2011 · HL
SP resistance markers &falciparum malaria transmission$162,000
R21 · FY2004 · AI
SP resistance markers &falciparum malaria transmission$162,000
R21 · FY2003 · AI